Sino Biopharmaceutical | 1177 - Ebit

Stock Price
6.39
Daily Change
0 0%
Monthly
-1.99%
Yearly
85.76%
Q1 Forecast
6.38

Sino Biopharmaceutical reported CNY5.18B in EBIT for its fiscal semester ending in June of 2025.





Ebit Change Date
Akebia Therapeutics USD 13.51M 27.82M Mar/2025
Alaunos Therapeutics USD -1.19M 148K Sep/2025
Avita Medical AUD -8.66M 1.61M Jun/2025
Cspc Pharmaceutical CNY 1.22B 60.54M Sep/2025
Dianthus Therapeutics USD -40.29M 5.36M Sep/2025
Ionis Pharmaceuticals USD -160.18M 304.96M Sep/2025
IQVIA Holdings USD 2.68B 2.1B Dec/2025
Jiangsu Hengrui CNY 1.41B 1.4B Sep/2025
Moderna USD -857M 597M Dec/2025
Organon & Co USD 388M 28M Sep/2025
Revvity USD 145.83M 47.49M Dec/2025
Sino Biopharmaceutical CNY 5.18B 3.32B Jun/2025
Tectonic Therapeutic USD -22.33M 4.03M Jun/2025
Viatris USD 234.5M 49.1M Sep/2025
Xeris Pharmaceuticals USD 7.89M 2.46M Sep/2025